Navigation Links
FLIPR Calcium Assay Kit Datasheet






Every major pharmaceutical company uses the Molecular Devices FLIPR fluorometric imaging plate reader system in its drug discovery process. The FLIPR Calcium Assay Kit from Molecular Devices provides the easiest way to get the best performance from your FLIPR system.

The FLIPR Calcium Assay Kit was developed and optimized for the FLIPR system to provide a fast, simple and reliable fluorescence-based assay for detecting changes in intracellular calcium. With this kit, calcium assays on FLIPR become a Mix-and-Read procedure in which cells are incubated with the kit reagents for up to one hour and transferred directly to the FLIPR system for evaluation. There are no intermediate wash steps involved.

The major benefit of the optimized assay is apparent in the quality of the data. The signal obtained with the FLIPR Calcium Assay Kit tends to be higher than that observed in cells loaded with fluo-3 and, at a minimum, comparable to that seen with fluo-4 dye-loaded cells. Furthermore, tighter CVs across 96- and 384-well plates are observed, leading to better results. Figures 1 and 2 show typical data using the FLIPR Calcium Assay Kit.

One advantage in any high throughput screening campaign is the reduced number of steps in the assay, which leads to even higher throughput when used with the FLIPR system. The kits simple procedure involves the direct addition of the kit reagents to the cell plate, incubation for 20 minutes to one hour, and then dire ct transfer of the plates to the FLIPR system for data collection. (See Figure 3.) The elimination of intermediate steps reduces valuable assay time and costs. Also, due to the improved kit chemistry, clear plates may be used instead of black-walled plates to reduce disposable costs significantly.

Another advantage in a high throughput screening campaign is increased convenience. Once dye-loaded with the kit reagents, cells are typically stable for several hours, maximizing assay flexibility. In addition, the FLIPR Calcium Assay Kit has been demonstrated to work equally well with both adherent and non-adherent cells. In many cases, poly-D-lysine coated plates are not required, further lowering the overall assay cost. With the FLIPR Calcium Assay Kit, non-adherent cells are less likely to lift off the plate, and they display greater responsiveness due in part to the elimination of multiple wash/centrifugation steps. Users consistently see equivalent and, in many cases, superior responses to those obtained using the conventional protocol.

For assay development on FLIPR or FLEXstation.

Calcium Assay Kit for FLIPR: Part Number: R8033
(10) reagent vials
(1) buffer bottle
Provides sufficient reagent for 100 plates (96- or 384-well)

Volume discounts given for quantities of 5, 10, and 50 unit orders.

Calcium Assay Kit for FLEXstation: Part Number: R8041
(10) reagent vials
(1) buffer bottle
Provides sufficient reagent for 10 plates (96- or 384-well)

USA 800-635-5577
UK +44-118-944-8000
Germany +49-89-9620-2340
Japan +06-6399-8211

Check our w eb site for a current listing of our worldwide distributors.

FLIPR is a registered trademark and FLEXstation is a trademark of Molecular Devices Corporation.

Contact your Molecular Devices representative for more information.

back to top



Page: All 1 2 3

Related biology technology :

1. FLIPR Calcium 3 Assay Kit Datasheet
2. FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses
3. Gq-coupled receptor assays: a comparison of FLEXstation and FLIPR
4. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
5. Cis-Reporting System Monitors Intracellular Calcium Mobilization
6. Cis-Reporting System Monitors Intracellular Calcium Mobilization
7. Calcium Plus Assay Kit, Superior Detection for Specialized Targets
8. Calcium Flux Assays using the LabChip 3000
9. HEK293 Calcium Flux Assay
10. A Positive Selection Assay for Mutation Analysis in Big Blue Animals
11. Luminol-enhanced Assay for Superoxide Anion (O2 face="Symbol" )
Post Your Comments:

(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: ... for financial services, but it also plays a fundamental part ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):